Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR5A1 Inhibitors

The olfactory receptor 5A1 (OR5A1), a member of the G protein-coupled receptor family, plays a key role in the detection of odor molecules. Its expression, predominantly located within the sensory epithelium of the nasal cavity, allows for the discrimination of an extensive array of odorant substances, contributing to the complexity of the sense of smell. The regulation of OR5A1, as with many genes, is subject to intricate control by various cellular mechanisms, which can include epigenetic modifications, transcription factor dynamics, and post-transcriptional processes. Understanding the pathways and compounds that can downregulate OR5A1 expression is of interest for researchers in fields ranging from sensory biology to environmental health, as it sheds light on how external factors can influence sensory perception at the molecular level. Several chemical compounds have been identified as potential inhibitors of OR5A1 expression, each acting through distinct molecular mechanisms. For instance, compounds like 5-Azacytidine and Trichostatin A target the epigenetic landscape of the OR5A1 gene. 5-Azacytidine can cause demethylation of the gene's promoter region, potentially leading to transcriptional silencing, while Trichostatin A may increase histone acetylation, which paradoxically can create a repressive chromatin state for this particular gene. Other substances, such as Mithramycin A and Actinomycin D, can bind directly to the DNA sequence of OR5A1, impeding the binding of transcription factors or the progression of RNA polymerase, respectively, thereby reducing gene expression. Additional compounds, including Curcumin and Resveratrol, are believed to inhibit the expression of OR5A1 by altering the activity of specific transcription factors and modifying the chromatin structure around the gene. The ability to fine-tune the expression of olfactory receptors like OR5A1 through chemical means opens a window into the sophisticated control of gene expression and the modulation of sensory functions.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound could demethylate the promoter region of the OR5A1 gene, leading to a state of transcriptional silence by preventing the binding of transcriptional activators necessary for OR5A1 transcription.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

By specifically inhibiting histone deacetylases, Trichostatin A could increase acetylation levels of histones associated with the OR5A1 gene, creating a chromatin structure that does not favor transcription initiation.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A can bind to DNA in the promoter region of OR5A1, directly obstructing the attachment of specific transcription factors that are critical for the initiation of OR5A1 gene transcription.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D may intercalate into DNA of the OR5A1 gene, obstructing the elongation phase of RNA polymerase during mRNA synthesis and consequentially reducing OR5A1 mRNA levels.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Curcumin could downregulate OR5A1 expression by inhibiting the activation of transcription factors such as AP-1, which may be essential for OR5A1 gene transcription initiation and promoter activity.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Resveratrol has the potential to downregulate OR5A1 by enhancing the deacetylation of histones in the promoter region of the OR5A1 gene, leading to tighter chromatin and decreased transcriptional activity.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium Butyrate could lead to hyperacetylation of histones near the OR5A1 gene locus, resulting in the reduction of transcriptional initiation and elongation events that contribute to OR5A1 expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG might decrease OR5A1 expression by altering the methylation status of its promoter region, leading to a chromatin conformation that is less accessible to the transcriptional machinery.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid could decrease OR5A1 expression by binding to retinoic acid receptors that interact with the OR5A1 promoter, resulting in the repression of transcriptional initiation complex assembly.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002 may reduce OR5A1 expression by hindering the PI3K/Akt signaling pathway, which is involved in the transcription of growth and survival genes, including possibly OR5A1.